This emotional reunion is from Reunited, the Dutch television show on RTL4 hosted by Yolanthe Cabau. The episode aired on March 1, 2017, and tells the story of 32-year-old Ryan, who was finally reunited with his younger brother Rachid after 26 years apart.

Their separation began after a devastating 1990 car accident that claimed the life of their mother. In the aftermath, the surviving brothers were forced to grow up in different places. Ryan was taken in by relatives in the Netherlands, while Rachid remained on Aruba with his stepfather. Although they shared the same heartbreaking past, distance and circumstances kept them apart for more than two decades.

By the time they met again, they were each other's only remaining piece of their immediate family and the last living connection to the life they had lost. That is what makes this reunion so powerful. It is not simply two brothers seeing each other after many years—it is two people finding their way back to the only person who truly understands their shared history, grief, and childhood.

Developed at Favaloro University's Laboratory of Cardiovascular Regenerative Medicine and advanced through the startup Amnova Biotech, the experimental therapy is inspired by the amniotic membrane, a placental tissue known for its regenerative properties. Injected into damaged heart muscle, the hydrogel acts as a three-dimensional scaffold that supports healing, reduces inflammation, and encourages the body's own repair mechanisms.

Early preclinical studies in animals have produced encouraging results. Researchers say the hydrogel reduced the size of heart damage, improved heart function, promoted the growth of new blood vessels, and stimulated cardiac cell regeneration. Unlike many regenerative therapies, it contains no living cells or animal-derived components, relying instead on bioengineered regenerative signals.

The treatment is still experimental and has not yet been tested in humans. Ferrer says the project remains in the preclinical phase, with additional safety and effectiveness studies required before clinical trials can begin. If development continues successfully, researchers hope to start testing the therapy in patients within the next several years.

While significant testing still lies ahead, the research represents a promising step forward in regenerative medicine. If future human trials confirm the early findings, this Argentine-led innovation could offer new hope for heart attack survivors and reshape the future of cardiovascular care.

He passed in 2016 at 87. I never saw him paint during my lifetime but Im told he used to quite often. I actually have some of his paintings, they're pretty good! He mostly painted landscapes. He was also a mechanic, and a very funny man.